Juliet Chijioke

ID Pharmacist. PGY2 ID @ Munson Medical Center, PGY1 @ Providence Portland Medical Center, PharmD @ UTHSC... Nature lover 🏞. Tweets are own opinion

[Juliet Chijioke @JulietChiji]

@DrLuisO @IDSAInfo @cbusky Congrats Dr. Ostrosky, well deserved!

[Juliet Chijioke @JulietChiji]

@TakaMatsuo_ID @MDAndersonNews @ut_infectious @POkhuysen @ChemalyRoy @HarrysTorres01 @eduardo_yepezg @10e_John @DrLuisO @benjbarnett64 @DBhamidipatee Congrats Taka!

[Juliet Chijioke @JulietChiji]

@TakaMatsuo_ID @MSG_ERC @MDAndersonNews @ut_infectious Congrats @TakaMatsuo_ID can’t wait to read it

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

✨️Excellent 🆕️review ✨️
Resistance in Pseudomonas aeruginosa: A Narrative Review of Antibiogram* Interpretation and Emerging Treatments
EnJoy #IDXposts #MedEd
Antibiogram= Susceptibility report
Ex: oprD loss of function/downregulation Antibiogram👇 https://t.co/hI5ZMUBCD4

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

Levofloxacin is less active against SM than either TMP/SMX or minocycline, and its role in treatment of minor infections is doubtful given the potential for the emergence of resistance during therapy #IDXposts #MedEd

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🔥Recently published RCTs in Infectious Diseases 🔥
1️⃣@asap_trial @NEJM
2️⃣SOAB RCT @CMIJournal
3️⃣ACORN RCT @JAMA_current
4️⃣ACT HIV RCT @NEJM
5️⃣SAFO RCT @NatureMedicine
6️⃣ERADICATE RCT @NEJM
#yournextJC #IDXposts
Thread 🧵

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

For non ID colleagues and ID ICYMI
these are the most important updates that you must know about the new CLSI "M100-Ed33"!
Updated Aminoglycoside Breakpoints for Enterobacterales & Pseudomonas aeruginosa
Background & Reasons for the Changes!
🌟Bookmark🌟
https://t.co/oZGlcidYqw

[Clinical Infectious Diseases @CIDJournal]

Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections

✅ Just Accepted
🆓 Freely Available
🔗 https://t.co/1DC5p1m0CF

[ACCP INFD PRN @accpinfdprn]

⭐️ Check out the new insight from SIDP on Triazole Antifungal TDM #IDTwitter
https://t.co/i38qp0VxNM

[Juliet Chijioke @JulietChiji]

@DrLuisO 🤣🤣🤣 that’s a good one

[Juliet Chijioke @JulietChiji]

@ut_infectious @MDAndersonNews @chiayuchiuID @monicgeorge @RitaWilsonDib1 @TakaMatsuo_ID Congrats y’all! Can’t wait to see all the amazing things you all are going to continue to do 🎉

[Takahiro Matsuo (Taka), MD @TakaMatsuo_ID]

【Early switch to oral antimicrobials in brain abscess: A narrative review】@CMIJournal Apr 27, 2023 🇩🇰

👉Great overview of studies describing use of early transition to PO in brain abscess! (Table 1)

https://t.co/Lr62Ja7TP8

@UT_Infectious #IDMedEd #IDFellow

[Juliet Chijioke @JulietChiji]

@TakaMatsuo_ID @fredhutch @MDAndersonNews Congrats Taka what an amazing opportunity!

[SIDP @SIDPharm]

Hot off the Press: New @CLSI_LabNews M100 Susceptibility Testing Reference now available! 🧫

Major update for aminoglycosides! Just in time for those annual antibiogram updates 🤓

Explore additional updates here: https://t.co/Y7b2nUd0ZG

[Sébastien Poulin @sebpoule]

💥CLSI M100 33rd Edition
Updates 👇 - A thread 🧵
#MicroRounds #IDtwitter

[Eric Macy @EricMacyMD]

1)There is a predictable rate of newly reported antibiotic “allergies” that will occur after all antibiotic use. Sulfonamides > penicillins > cephalosporins, macrolides, quinolones, clindamycin. #ASPchat Clinical Pearls

[MSGERC @MSG_ERC]

Pharmacodynamics, Mechanisms of Action and Resistance, and Spectrum of Activity of New Antifungal Agents

New review from Nathan Wiederhold of the Fungus Testing Laboratory at UTHSA

https://t.co/mBhdUIGbtd

[JAC-AMR @jac_amr]

🔥NEW🔥 PRO-CON Debate on the role of carbapenems in infections caused by Enterobacterales resistant to ceftriaxone. #AMR @BSACandJAC @IDdocAdi @ABsteward

[Brad Spellberg @BradSpellberg]

Given the popularity of the Shorter Is Better website, and the need to move ID to oral Abx for better patient care, I've added a new webpage: oral Abx tables/references for osteo, bacteremia, endocarditis. Would love feedback. Am I missing studies? https://t.co/F9Whl43PhE

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

NEW 🔥🔥 #CID @eliowa et Al
Comparative Effectiveness of Switching to Daptomycin Versus Remaining on Vancomycin Among Patients With (MRSA) BSI
Switching to dapto within 3 days of initial receipt of vanco is associated with ⬇️ 30-day mortality #IDTwitter https://t.co/LmGwbCOrc3